欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2003, Vol. 8 ›› Issue (2): 136-138.

• 研究原著 • 上一篇    下一篇

合用盐酸黄连素前后环孢素A 的健康人体药动学研究1

吴笑春, 仲明远, 辛华雯, 李罄, 余爱荣, 周秋香   

  1. 广州军区武汉总医院临床药理科, 武汉 430070, 湖北
  • 收稿日期:2002-11-11 修回日期:2002-11-30 出版日期:2003-04-26 发布日期:2020-11-25
  • 通讯作者: 吴笑春, 女, 主任药师, 从事临床药理和临床药学工作。Tel:027-87879797-78688 E-mail:armyzhong@sina.com
  • 基金资助:
    1 湖北省自然科学基金面上项目(№:2002AB114)

Pharmacokinetics of cyclosporin A coadministrated with berberine in Chinese healthy volunteers1

WU Xiao-Chun, ZHONG Ming-Yuan, XIN Hua-Wen, LI Qing, YU Ai-Rong, ZHOU Qiu-Xiang   

  1. Department of Clinical Pharmacology, Wuhan General Hospital, Guangzhou Military Command, Wuhan 430070, Hubei
  • Received:2002-11-11 Revised:2002-11-30 Online:2003-04-26 Published:2020-11-25

摘要: 目的: 研究健康受试者合用盐酸黄连素(Ber)前后环孢素A(CsA) 的动力学过程, 以分析两药相互作用发生的部位。方法: 6 名健康男性志愿者在单剂口服CsA (6 mg·kg-1) 后开始连续服用Ber 13 d(300 mg·bid-1), 然后再单剂口服CsA (6 mg·kg-1),每次口服CsA 后即按时采血, 并用FPIA 法测定全血CsA 浓度, 并计算出药动学参数。结果: 合用Ber 前后CsA 的主要药动学参数Ka 分别为0.91 ±0.30h-1 和1.09 ±0.35 h-1;T1 2β分别为6.18 ±0.94 h 和6.86 ±1.27 h;AUC0 -24 分别为11.0 ±1.6和10.6 ±1.6 mg·h-1 ·L-1;CL(s) 分别为34.3 ±6.7 L·h-1 和36.6 ±9.3 L·h-1;Tpeak均为1.5 ±0.6 h;Cmax 分别为1.8 ±0.4 mg·L-1和1.9 ±0.3 mg·L-1结论: 在健康志愿者合用Ber 前后CsA 的药动学参数没有显著差异, 推测Ber 对CsA 的影响部位可能主要在肠道。

关键词: 药理学, 环孢素A, 盐酸黄连素, 药物动力学, 健康志愿者

Abstract: AIM: To study the pharmacokinetics of cyclosporin A (CsA) with or without combination of berberine chloride (Ber) in healthy volunteers. METHODS: After taking CsA of a single dosage of 6 mg·kg -1, 6 healthy male volunteers were administrated with Ber at 300 mg twice daily for 13 days and on day 15 took CsA of a single dosage at 6 mg·kg -1 again.The blood concentrations of CsA before and after coadministration with Ber were determined by fluorescence polarization immunoassay (FPIA) and the pharmacokinetic parameters were calculated by 3p87 program. RESULTS: The main pharmacokinetic parameters of CsA before and after coadministration of Ber were as follow:K a were 0.913 ±0.30 h -1 and 1.092 ±0.348 h -1;T1 2β were 6.18 ±0.94 h and 6.86 ±1.27 h;AUC0 -24 were 11.0 ±1.6mg·h·L -1 and 10.6 ±1.6 mg·h -1 ·L -1;CL(s) were 34.3 ±6.7 L· h -1 and 36.6 ±9.3 L·h -1;Cmax were 1.8 ±0.4 mg· L -1 and 1.9 ±0.4 mg·L -1, respectively.Both values of Tpeak were 1.5 ±0.55 h; CONCLUSION: The pharmacokinetic parameters of CsA before and after coadministration with Ber have no significant differences in healthy volunteers.Therefore, the action site of Ber influencing CsA is supposed to lie in intestines.

Key words: pharmacology, cyclosporin A, berberine chloride, pharmacokinetics, healthy volunteers

中图分类号: